221 related articles for article (PubMed ID: 28275106)
1. Transfer of disrupted-in-schizophrenia 1 aggregates between neuronal-like cells occurs in tunnelling nanotubes and is promoted by dopamine.
Zhu S; Abounit S; Korth C; Zurzolo C
Open Biol; 2017 Mar; 7(3):. PubMed ID: 28275106
[TBL] [Abstract][Full Text] [Related]
2. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.
Trossbach SV; Bader V; Hecher L; Pum ME; Masoud ST; Prikulis I; Schäble S; de Souza Silva MA; Su P; Boulat B; Chwiesko C; Poschmann G; Stühler K; Lohr KM; Stout KA; Oskamp A; Godsave SF; Müller-Schiffmann A; Bilzer T; Steiner H; Peters PJ; Bauer A; Sauvage M; Ramsey AJ; Miller GW; Liu F; Seeman P; Brandon NJ; Huston JP; Korth C
Mol Psychiatry; 2016 Nov; 21(11):1561-1572. PubMed ID: 26754951
[TBL] [Abstract][Full Text] [Related]
3. Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport.
Atkin TA; Brandon NJ; Kittler JT
Hum Mol Genet; 2012 May; 21(9):2017-28. PubMed ID: 22291444
[TBL] [Abstract][Full Text] [Related]
4. Aggregated proteins in schizophrenia and other chronic mental diseases: DISC1opathies.
Korth C
Prion; 2012; 6(2):134-41. PubMed ID: 22421208
[TBL] [Abstract][Full Text] [Related]
5. Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease.
Leliveld SR; Bader V; Hendriks P; Prikulis I; Sajnani G; Requena JR; Korth C
J Neurosci; 2008 Apr; 28(15):3839-45. PubMed ID: 18400883
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of Disrupted in Schizophrenia 1 arises from a central region of the protein.
Zaharija B; Bradshaw NJ
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110923. PubMed ID: 38135095
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.
Kassan A; Egawa J; Zhang Z; Almenar-Queralt A; Nguyen QM; Lajevardi Y; Kim K; Posadas E; Jeste DV; Roth DM; Patel PM; Patel HH; Head BP
J Neurophysiol; 2017 Jan; 117(1):436-444. PubMed ID: 27832597
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y neuronal network dysfunction in the frontal lobe of a genetic mouse model of schizophrenia.
Morosawa S; Iritani S; Fujishiro H; Sekiguchi H; Torii Y; Habuchi C; Kuroda K; Kaibuchi K; Ozaki N
Neuropeptides; 2017 Apr; 62():27-35. PubMed ID: 28073591
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of the protein TRIOBP-1 and its potential relevance to schizophrenia.
Bradshaw NJ; Bader V; Prikulis I; Lueking A; Müllner S; Korth C
PLoS One; 2014; 9(10):e111196. PubMed ID: 25333879
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia.
Umeda K; Iritani S; Fujishiro H; Sekiguchi H; Torii Y; Habuchi C; Kuroda K; Kaibuchi K; Ozaki N
Synapse; 2016 Dec; 70(12):508-518. PubMed ID: 27421906
[TBL] [Abstract][Full Text] [Related]
11. DISC1 and the aggresome: a disruption to cellular function?
Atkin T; Kittler J
Autophagy; 2012 May; 8(5):851-2. PubMed ID: 22617441
[TBL] [Abstract][Full Text] [Related]
12. Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.
Jacobi AA; Halawani S; Lynch DR; Lin H
Neurosci Lett; 2019 Jan; 692():107-114. PubMed ID: 30391323
[TBL] [Abstract][Full Text] [Related]
13. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.
Deng QS; Dong XY; Wu H; Wang W; Wang ZT; Zhu JW; Liu CF; Jia WQ; Zhang Y; Schachner M; Ma QH; Xu RX
Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786
[TBL] [Abstract][Full Text] [Related]
14. Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes.
Ottis P; Bader V; Trossbach SV; Kretzschmar H; Michel M; Leliveld SR; Korth C
Biol Psychiatry; 2011 Oct; 70(7):604-10. PubMed ID: 21531389
[TBL] [Abstract][Full Text] [Related]
15. Altered subcellular distribution of the 75-kDa DISC1 isoform, cAMP accumulation, and decreased neuronal migration in schizophrenia and bipolar disorder: implications for neurodevelopment.
Muñoz-Estrada J; Benítez-King G; Berlanga C; Meza I
CNS Neurosci Ther; 2015 May; 21(5):446-53. PubMed ID: 25620115
[TBL] [Abstract][Full Text] [Related]
16. Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses.
Sawamura N; Sawa A
Ann N Y Acad Sci; 2006 Nov; 1086():126-33. PubMed ID: 17185511
[TBL] [Abstract][Full Text] [Related]
17. Generation, purification, and characterization of cell-invasive DISC1 protein species.
Bader V; Ottis P; Pum M; Huston JP; Korth C
J Vis Exp; 2012 Aug; (66):e4132. PubMed ID: 22952026
[TBL] [Abstract][Full Text] [Related]
18. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs.
Lipska BK; Peters T; Hyde TM; Halim N; Horowitz C; Mitkus S; Weickert CS; Matsumoto M; Sawa A; Straub RE; Vakkalanka R; Herman MM; Weinberger DR; Kleinman JE
Hum Mol Genet; 2006 Apr; 15(8):1245-58. PubMed ID: 16510495
[TBL] [Abstract][Full Text] [Related]
19. Disrupted-in-schizophrenia 1 Protein Misassembly Impairs Cognitive Flexibility and Social Behaviors in a Transgenic Rat Model.
Wang AL; Chao OY; Nikolaus S; Lamounier-Zepter V; Hollenberg CP; Lubec G; Trossbach SV; Korth C; Huston JP
Neuroscience; 2022 Jun; 493():41-51. PubMed ID: 35461978
[TBL] [Abstract][Full Text] [Related]
20. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria.
James R; Adams RR; Christie S; Buchanan SR; Porteous DJ; Millar JK
Mol Cell Neurosci; 2004 May; 26(1):112-22. PubMed ID: 15121183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
